Corrigendum to “Sangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymerase” [Antivir. Res. 218 (2023) 105716–105728, doi: 10.1016/j.antiviral.2023.105716]

Autor: Bennett, Ryan P., Yoluç, Yasemin, Salter, Jason D., Ripp, Alexander, Jessen, Henning J., Kaiser, Stefanie M., Smith, Harold C.
Zdroj: In Antiviral Research November 2023 219
Databáze: ScienceDirect